Search and treat strategy to eliminate Helicobacter pylori associated ulcer disease

Gut

Volumn 48, Issue 4, 2001, Pages 567-570

  De Boer, W A ^a,b   Tytgat, G N J ^c  

^a BERNHOVEN HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; ANTIBIOTIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; PROKINETIC AGENT;

CASE FINDING; DIAGNOSTIC PROCEDURE; DRUG CHOICE; DRUG COST; DYSPEPSIA; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; PATIENT SELECTION; PEPTIC ULCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

ADULT; AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS;

EID: 0035080604     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.48.4.567     Document Type: Review

References (51)

1. Health impact of peptic ulcer in the United States
2. The impact of peptic ulcer disease and infection with Helicobacter pylori on life expectancy
3. Helicobacter pylori eradication as a surrogate marker for the reduction of duodenal ulcer recurrence
4. Eradication of Helicobacter pylori does not decrease the long-term use of acid-suppressive medication
5. Randomized controlled comparison of nitoimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia
6. Community dyspepsia clinics reduce maintenance therapy for peptic ulceration in Helicobacter positive and negative patients
7. Effect of Helicobacter pylori treatment on outpatient pharmacy costs
8. Review article. Helicobacter pylori and gastro-oesophageal reflux disease - Clinical implications and management
9. Helicobacter pylori and reflux disease
10. Why don't physicians follow clinical practice guidelines? A framework for improvement
11. Utilazition of H2RA in the era of proton pump inhibitor and H pylori infection
12. Influence of the NIH consensus conference on Helicobacter pylori on physician prescribing among a Medicaid population
13. Treatment policy after hospitalization for gastroduodenal ulcer hemorrhage: A follow-up study
14. Improvement in adherence to guidelines for Helicobacter pylori in patients hospitalized for peptic ulcer disease
15. Screening for Helicobacter pylori and nonsteroidal anti-inflammatory drug use in Medicare patients hospitalized with peptic ulcer disease
16. The quality of care for Medicare patients with peptic ulcer disease
17. Prescribing patterns for dyspepsia in primary care: A prospective study of selected general practitioners
18. Eradication of Helicobacter pylori in general practice
19. Helicobacter pylori outpatient treatment at a university hospital
20. Treatment of Helicobacter pylori
21. Eradication of Helicobacter pylori and non-ulcer dyspepsia
22. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care
23. Distinct profiles of gastritid in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication
24. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping
25. Disease management in ulcer disease
26. Helicobacter pylori test and treat strategy for dyspeptic patients
27. Functional dyspepsia has a good prognosis irrespective of H. pylori status. Long-term follow-up of symptoms after anti-Helicobacter treatment
28. How well do general practitioners manage dyspepsia?
29. Factors affecting the decision to consult with dyspepsia: Comparison of consulters and non-consulters
30. Review article: The initial management of uninvestigated dyspepsia in younger patients - The value of symptom-guided strategies should be reconsidered
31. The management of Helicobacter pylori infection in primary care. Guidelines from the ESPCG
32. Seroprevalence of Helicobacter pylori infection and presence of dyspepsia in military recruits in the Netherlands
33. Do ulcers burn out or burn on? Managing duodenal ulcer diathesis in the Helicobacter pylori era
34. Helicobacter pylori infection status in relation to antibiotic and non-steroidal prescribing in patients on maintenance treatment for chronic duodenal ulcer
35. Helicobacter treatment with quadruple therapy in primary health care for patients with a history of ulcer disease
36. Helicobacter pylori treatment instead of maintenance therapy for peptic ulcer disease: The effectiveness of case-finding in general practice
37. Management of patients with known duodenal ulcer disease but unknown Helicobacter pylori status: A decision analysis
38. Clinical and economic effects of immediate Helicobacter eradication for patients with documented peptic ulcer disease but unknown Helicobacter pylori status
39. A cost analysis of a Helicobacter pylori eradication strategy in a large health maintenance organization
40. Long-term acid suppressing treatment in general practice
41. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting
42. Repeat prescribing of ulcer healing drugs in general practice - Prevalence and underlying diagnosis
43. A population-based inventarisation of long-term acid suppressant use in 24 general practices in the Netherlands
44. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care
45. Costs and benefits of a test and treat strategy in H. pylori infected subjects: A prospective and controlled intervention study in general practice
46. The prevalence of Helicobacter pylori infection in patients receiving long-term H2 receptor antagonists in general practice: Clinical and financial consequences of eradication using omeprazole plus amoxycillin or "triple therapy"
47. A pilot study of a randomized controlled trial of pragmatic eradication of Helicobacter pylori in primary care
48. Clinical and economic outcomes of treating Helicobacter pylori in patients taking chronic acid suppression therapy
49. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection
50. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
51. Does Helicobacter pylori affect the management of gastroesophageal reflux disease?